PET Imaging of brain muscarinic receptors with 18F-Fluorobenzyl-Dexetimide: A first in human study-Reference-Cited by-同舟云学术

PET Imaging of brain muscarinic receptors with 18F-Fluorobenzyl-Dexetimide: A first in human study

Published:2021-10 Issue: Volume:316 Page:111354
ISSN:0925-4927
Container-title:Psychiatry Research: Neuroimaging
language:en
Short-container-title:Psychiatry Research: Neuroimaging

Author:

Rowe Christopher C.,Krishnadas Natasha,Ackermann Uwe,Doré Vincent,Goh Rachel Y.W.,Guzman Rodney,Chong Lee,Bozinovski Svetlana,Mulligan Rachel,Kanaan Richard,Dean Brian,Villemagne Victor L.

Publisher

Elsevier BV

Subject

Psychiatry and Mental health,Radiology Nuclear Medicine and imaging,Neuroscience (miscellaneous)

Reference26 articles.

1. 123I-iododexetimide preferentially binds to the muscarinic receptor subtype M1 in vivo;Bakker;J. Nucl. Med.,2015

2. Basal forebrain cholinergic circuits and signaling in cognition and cognitive decline;Ballinger;Neuron,2016

3. Human dosimetry and biodistribution of iodine-123-iododexetimide: a SPECT imaging agent for cholinergic muscarinic neuroreceptors;Boundy;J. Nucl. Med.,1995

4. Reduced posterior cingulate binding of I-123 iodo-dexetimide to muscarinic receptors in mild Alzheimer’s disease;Boundy;J. Clin. Neurosci.,2005

5. Decreased muscarinic receptors in the dorsolateral prefrontal cortex of subjects with schizophrenia;Dean;Mol. Psychiatry,2002

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Muscarinic M1 and M4 receptor agonists for schizophrenia: promising candidates for the therapeutic arsenal;Expert Opinion on Investigational Drugs;2023-11-29

2. Imaging Cholinergic Receptors in the Brain by Positron Emission Tomography;Journal of Medicinal Chemistry;2023-08-16

3. Lower levels of cortical [3H]pirenzepine binding to postmortem tissue defines a sub-group of older people with schizophrenia with less severe cognitive deficits;Schizophrenia Research;2023-05

4. A growing understanding of the role of muscarinic receptors in the molecular pathology and treatment of schizophrenia;Frontiers in Cellular Neuroscience;2023-02-22

5. Molecular Imaging in Parkinsonian Disorders—What’s New and Hot?;Brain Sciences;2022-08-27